Langford et al. Abatacept NOT effective in GPA in ABROGATE RCT. 65 patients. Relapse/worsening in 62% vs 68%. No difference in any secondary end-point. @RheumNow #ACR24 Abstr#0823 https://t.co/yRFZ2diJFF https://t.co/LgXkPnDArE
Links:
A Randomized, Double-Blind, Placebo-Controlled Trial of Abatacept for the Treat…
https://acrabstracts.org/abstract/a-randomized-double-blind-placebo-controlled-…
16-11-2024